Transient Ischemic Attack Market
Global Transient Ischemic Attack Market Research By Diagnosis (Carotid Ultrasonography, CT Scan and CT Angiography Scan, MRI Scan and MR Angiography, Echocardiography, Electrocardiogram and Other), By Treatment (Medication, Surgery, and Angioplasty), and By End-User (Hospital & Clinics, Research Institutes, and Diagnostic Centers) Forecast 2021-2027
The global transient ischemic attack market is growing at a considerable CAGR of 6.1% during the forecast period. Changing lifestyle and eating habits is one of the prime factors affecting and driving the market. The increasing pervasiveness of neurological disorder among the population and reimbursement policies that are favorable is also estimated to be the prime factors that are contributing significantly towards the growth of the market. However, the high-cost involvement in treatment and lack of awareness with regards to diagnosis along with treatment of transient ischemic attack is one of the major factors constraints that are hindering the growth of the global transient ischemic attack market across the globe.
However, rising investments in R&D by government organizations along with advancement in technology in diagnostic tools are some of the key factors that are creating opportunities for the market. New product launches and collaboration in the market are likely to drive the growth of the global transient ischemic attack market. For instance, in October 2020, Acticor Biotech SAS which is one of the clinical-stage biotechnology companies had set forth the completion of its ACTIMIS dose-escalation phase first. This was done for patients suffering from acute ischemic stroke and 60 patients enrolled from 6 European countries that include France, Belgium, and Germany among others.
Impact of COVID-19 on the Global Transient Ischemic Attack Market
The global transient ischemic attack is hardly hit by the COVID-19 pandemic since December 2019. The COVID-19 pandemic in the major economies has disrupted manufacturing and transportation. However, the proper treatment was been given by physicians to patients suffering from a mini-stroke and cardiovascular diseases.
Segmental Outlook
The market is segmented based on diagnosis, treatment, end-users. Based on the diagnosis, the market is segmented into carotid ultrasonography, CT scan and CT angiography scan, MRI scan and MR angiography, echocardiography, electrocardiogram and other. By treatment, the market is segmented into medication, surgery and angioplasty. Further, by end-users, market is segmented hospital & clinics, research institutes and diagnostic centers.
Global Transient Ischemic Attack Market Share by Diagnosis Method 2020 (%)
Based on the diagnosis method, MRI scan and MR angiography is important methods in order to manage the diagnosis-related with the mini-stroke. Through this MRI scan and MR angiography, information can be easily received with regards to stroke as it offers quality imaging. Therefore, it is likely to drive the growth of the transient ischemic attack market.
Regional Outlooks
The global transient ischemic attack market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America held a considerable share in 2020 in the global transient ischemic attack market. Some factors that are boosting the market growth in North America are the increasing pervasiveness of cardiovascular diseases along with the presence of the leading players in the market. Additionally, increasing investment in health care expenditure in the region along with technology advancement is boosting the market in this region. Moreover, in Europe, increasing awareness with regards to treatment and diagnosis of minor stroke is one of the prime factors involved in the growth of the market in the region.
Global Transient Ischemic Attack Market, by Region 2021-2027
Asia-Pacific will have Considerable Growth in the Global Transient Ischemic Attack Market
Asia-Pacific region is expected to witness significant growth opportunities for the market. Increasing tobacco and alcohol along with rising changes in lifestyle in emerging economies of the region are likely to drive the growth of the regional market. Further, due to rising health care expenditure along with the rising pervasiveness of cardiac disorders and change in dietary habits in India, China and South Korea are also some of the factors that are affecting and impacting the growth in this market.
Market Player Outlook
Key players of the global transient ischemic attack market are Abbott, Cardinal Health, electroCore, Inc., Medtronic, and Siemens Healthcare Pvt. Ltd., among others. To survive in the market, these players adopt different marketing strategies such as product launches and collaboration. For instance, in July 2020, AstraZeneca had set forth that US Food and Drug Administration (FDA) had given acceptance to its supplemental New Drug Application (sNDA) and for Brilinta (ticagrelor). Brilinta got a priority review for patients who had experienced an acute ischemic stroke or transient ischemic attack (TIA) as it decreases the subsequent.
In December 2020, DAIICHI SANKYO CO. LTD. had announced that it had filled in japan an application regarding the Antiplatelet Agent, Prasugrel Hydrochloride in order to elaborate for preventing of recurrence of ischemic stroke on the basis of its phase 3 study.
In April 2019, Medtronic had introduced Solitaire X Revascularization device in the US. This is considered to be the first device to be used in patients in order to do treatment of acute ischemic stroke. Through this device, it had supported every physician in order to give proper treatment to patients for effective recovery from stroke in the industry.
In July 2019, Medtronic had signed an agreement with one of the artificial intelligence (AI) stroke care companies name Viz.ai. Through this agreement, the company will look forward to provide proper information and new products related to medical devices and digital health along with complementing the existing ones.
The Report Covers
- Market value data analysis of 2020 and forecast to 2027.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global transient ischemic attack market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Transient Ischemic Attack Industry
• Recovery Scenario of Global Transient Ischemic Attack Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Transient Ischemic Attack Market by Diagnosis
5.1.1. Carotid Ultrasonography
5.1.2. CT Scan and CT Angiography Scan
5.1.3. MRI Scan and MR Angiography
5.1.4. Echocardiography
5.1.5. Electrocardiogram
5.1.6. Other
5.2. Global Transient Ischemic Attack Market by Treatment
5.2.1. Medication
5.2.2. Surgery
5.2.3. Angioplasty
5.3. Global Transient Ischemic Attack Market by End-Users
5.3.1. Hospital & Clinics
5.3.2. Research Institutes
5.3.3. Diagnostic Centers
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott
7.2. Acticor Biotech SAS
7.3. AstraZeneca
7.4. Bayer AG
7.5. Boston Scientific Corp.
7.6. Cardinal Health.
7.7. DAIICHI SANKYO CO. LTD.
7.8. electroCore, Inc.
7.9. Lilly
7.10. General Electric
7.11. LivaNova PLC
7.12. Medtronic
7.13. Merck KgaA
7.14. Novartis AG
7.15. Novo Nordisk A/S
7.16. Pfizer Inc.
7.17. Sanofi
7.18. Siemens Healthcare Pvt. Ltd.
7.19. Stryker
7.20. Terumo Corp.
7.21. Zocere, Inc.
1. GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
2. GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET BY DIAGNOSIS, 2020-2027($ MILLION)
3. GLOBAL CAROTID ULTRASONOGRAPHY MARKET BY REGION, 2020-2027($ MILLION)
4. GLOBAL CT SCAN AND CT ANGIOGRAPHY SCAN MARKET BY REGION, 2020-2027($ MILLION)
5. GLOBAL MRI SCAN AND MR ANGIOGRAPHY MARKET BY REGION, 2020-2027($ MILLION)
6. GLOBAL ECHOCARDIOGRAPHY MARKET BY REGION, 2020-2027($ MILLION)
7. GLOBAL ELECTROCARDIOGRAM MARKET BY REGION, 2020-2027($ MILLION)
8. GLOBAL OTHER MARKET BY REGION, 2020-2027($ MILLION)
9. GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET BY TREATMENT, 2020-2027($ MILLION)
10. GLOBAL MEDICATION MARKET BY REGION, 2020-2027($ MILLION)
11. GLOBAL SURGERY BY REGION, 2020-2027($ MILLION)
12. GLOBAL ANGIOPLASTY BY REGION, 2020-2027($ MILLION)
13. GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET BY END-USERS, 2020-2027($ MILLION)
14. GLOBAL HOSPITAL & CLINICS MARKET BY REGION, 2020-2027($ MILLION)
15. GLOBAL RESEARCH INSTITUTES MARKET BY REGION, 2020-2027($ MILLION)
16. GLOBAL DIAGNOSTIC CENTERS MARKET BY REGION, 2020-2027($ MILLION)
17. GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027($ MILLION)
18. NORTH AMERICAN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
19. NORTH AMERICAN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027 ($ MILLION)
20. NORTH AMERICAN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027($ MILLION)
21. NORTH AMERICAN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027($ MILLION)
22. EUROPEAN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
23. EUROPEAN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027($ MILLION)
24. EUROPEAN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027($ MILLION)
25. EUROPEAN TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027($ MILLION)
26. ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
27. ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027($ MILLION)
28. ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027($ MILLION)
29. ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027($ MILLION)
30. REST OF WORLD TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2020-2027($ MILLION)
31. REST OF WORLD TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027($ MILLION)
32. REST OF WORLD TRANSIENT ISCHEMIC ATTACK MARKET RESEARCH AND ANALYSIS BY END-USERS, 2020-2027($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET, 2020-2027 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL TRANSIENT ISCHEMIC ATTACK SHARE BY SEGMENT, 2020-2027 ($ MILLION)
3. RECOVERY OF GLOBAL TRANSIENT ISCHEMIC ATTACK, 2021-2027 (%)
1. GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY DIAGNOSIS, 2020 VS 2027 (%)
2. GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY TREATMENT, 2020 VS 2027 (%)
3. GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY END-USER, 2020 VS 2027 (%)
4. GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
5. GLOBAL CAROTID ULTRASONOGRAPHY MARKET BY REGION, 2020 VS 2027 (%)
6. GLOBAL CT SCAN AND CT ANGIOGRAPHY SCAN MARKET BY REGION, 2020 VS 2027 (%)
7. GLOBAL MRI SCAN AND MR ANGIOGRAPHY MARKET BY REGION, 2020 VS 2027 (%)
8. GLOBAL ECHOCARDIOGRAPHY MARKET BY REGION, 2020 VS 2027 (%)
9. GLOBAL ELECTROCARDIOGRAM MARKET BY REGION, 2020 VS 2027 (%)
10. GLOBAL OTHER MARKET BY REGION, 2020 VS 2027 (%)
11. GLOBAL MEDICATION MARKET BY REGION, 2020 VS 2027 (%)
12. GLOBAL SURGERY MARKET BY REGION, 2020 VS 2027 (%)
13. GLOBAL ANGIOPLASTY MARKET BY REGION, 2020 VS 2027 (%)
14. GLOBAL HOSPITAL & CLINICS MARKET BY REGION, 2020 VS 2027 (%)
15. GLOBAL RESEARCH INSTITUTES MARKET BY REGION, 2020 VS 2027 (%)
16. GLOBAL DIAGNOSTIC CENTERS MARKET BY REGION, 2020 VS 2027 (%)
17. US TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
18. CANADA TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
19. UK TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
20. FRANCE TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
21. GERMANY TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
22. ITALY TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
23. SPAIN TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
24. REST OF EUROPE TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
25. INDIA TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
26. CHINA TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
27. JAPAN TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
28. SOUTH KOREA TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
29. REST OF ASIA-PACIFIC TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
30. REST OF THE WORLD TRANSIENT ISCHEMIC ATTACK MARKET SIZE, 2020-2027 ($ MILLION)
